메뉴 건너뛰기




Volumn 347, Issue 7926, 2013, Pages

The case for licensing cytosine now for smoking cessation is overwhelming

Author keywords

[No Author keywords available]

Indexed keywords

CYTISINE; NICOTINE PATCH;

EID: 84885056974     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f5736     Document Type: Letter
Times cited : (9)

References (3)
  • 1
    • 84883759957 scopus 로고    scopus 로고
    • Cytisine, the world's oldest smoking cessation aid
    • 23 August.
    • Prochaska JJ, Das S, Benowitz NL. Cytisine, the world's oldest smoking cessation aid. BMJ 2013;347:f5198. (23 August.)
    • (2013) BMJ , vol.347
    • Prochaska, J.J.1    Das, S.2    Benowitz, N.L.3
  • 2
    • 84885842999 scopus 로고    scopus 로고
    • Cytisine and the failure to market and regulate for human health
    • published online 1 Aug
    • Aveyard P, West R. Cytisine and the failure to market and regulate for human health. Thorax 2013; published online 1 Aug.
    • (2013) Thorax
    • Aveyard, P.1    West, R.2
  • 3
    • 84859261209 scopus 로고    scopus 로고
    • A direct method and ICER tables for the estimation of the cost-effectiveness of smoking cessation interventions in general populations: Application to a new cytisine trial and other examples
    • Stapleton JA, West R. A direct method and ICER tables for the estimation of the cost-effectiveness of smoking cessation interventions in general populations: application to a new cytisine trial and other examples.. Nicotine Tob Res 2012;14:463-71.
    • (2012) Nicotine Tob Res , vol.14 , pp. 463-471
    • Stapleton, J.A.1    West, R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.